跳到正文
原文
Nature 健康护理主题·· 10 天前AI 评分30

Rituximab 不优于硫唑嘌呤用于 EGPA 维持缓解

Rituximab not superior to azathioprine for EGPA remission maintenance

AI 导读

一项涉及 98 名成人 EGPA 患者的随机对照试验 MAINRITSEG 结果显示,利妥昔单抗与硫唑嘌呤在维持缓解方面的效果无显著差异(P = 0.38)。患者接受泼尼松 ≤7.5 mg 每日剂量治疗时,在缓解状态下的累积周数无明显区别(利妥昔单抗组 91 周 vs 硫唑嘌呤组 96 周)。

正文
  • Research Highlight
  • Published: 10 November 2026

Vasculitis

Nature Reviews Rheumatology (2026) Cite this article

Results of the MAINRITSEG randomized controlled trial indicate that rituximab is no more effective than azathioprine for maintaining remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA).

The investigator-initiated trial involved 98 adults with newly diagnosed or relapsing EGPA who had achieved a state of remission within the past year. Participants were randomly allocated to receive treatment with either rituximab or azathioprine plus a standardized prednisone tapering regimen. During the 28-month study, the number of accrued weeks spent in remission while receiving prednisone at a dose of ≤7.5 mg daily was not significantly different between the rituximab and azathioprine groups (91 weeks vs 96 weeks; P = 0.38).

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

32.70 € / 30 days cancel any time

Learn more

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

39,95 €

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Author information

Authors and Affiliations

  1. Nature Reviews Rheumatology http://www.nature.com/nrrheum/

    Sarah Onuora

Authors

  1. Sarah Onuora

Corresponding author

Correspondence to Sarah Onuora.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onuora, S. Rituximab not superior to azathioprine for EGPA remission maintenance. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01465-4

Download citation

  • Published: 10 November 2026

  • Version of record: 10 November 2026

  • DOI: https://doi.org/10.1038/s41584-026-01465-4

来源:Nature 健康护理主题 · nature.com